Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 8 (August)

1. Angiogenesis in colorectal cancer: prognostic and therapeutic implications.
   Am J Clin Oncol, 29(4): 408-17. [Abstract] [Full-text]
2. Do MSI-L sporadic colorectal tumors develop through "mild mutator pathway"?
   Am J Clin Oncol, 29(4): 364-70. [Abstract] [Full-text]
3. The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients.
   Clin Chim Acta, 371(1): 143-7. [Abstract] [Full-text]
4. Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway.
   Am J Physiol Cell Physiol, 291(3): C433-44. [Abstract] [Full-text]
5. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
   Cancer Chemother Pharmacol, 58(5): 692-8. [Abstract] [Full-text]
6. Tumour-expressed tissue factor inhibits cellular cytotoxicity.
   Cancer Immunol Immunother, 55(11): 1301-8. [Abstract] [Full-text]
7. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
   Int J Radiat Oncol Biol Phys, 66(1): 206-11. [Abstract] [Full-text]
8. Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy.
   Int J Radiat Oncol Biol Phys, 66(1): 195-200. [Abstract] [Full-text]
9. A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer.
   Int J Radiat Oncol Biol Phys, 66(1): 201-5. [Abstract] [Full-text]
10. Temporal relationship between prostate brachytherapy and the diagnosis of colorectal cancer.
    Int J Radiat Oncol Biol Phys, 66(1): 48-55. [Abstract] [Full-text]
11. Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older.
    Arch Intern Med, 166(15): 1626-31. [Abstract] [Full-text]
12. The Kraske procedure: a critical analysis of a surgical approach for mid-rectal lesions.
    J Surg Oncol, 94(3): 194-202. [Abstract] [Full-text]
13. Surgical outcomes after total mesorectal excision for rectal cancer.
    J Surg Oncol, 94(3): 182-93; discussion 181. [Abstract] [Full-text]
14. Distinctive clinicopathological features of Ki-ras mutated colorectal cancers.
    J Surg Oncol, 94(3): 234-41. [Abstract] [Full-text]
15. Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs.
    J Natl Cancer Inst, 98(16): 1118-28. [Abstract] [Full-text]
16. Screening for colorectal cancer by faecal occult blood test: why people choose to refuse.
    Intern Med J, 36(9): 607-10. [Abstract] [Full-text]
17. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma.
    J Clin Oncol, 24(24): 4011-9. [Abstract] [Full-text]
18. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?
    J Clin Oncol, 24(24): 3939-45. [Abstract] [Full-text]
19. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation.
    Int J Cancer, 119(6): 1249-53. [Abstract] [Full-text]
20. Silencing of the UCHL1 gene in human colorectal and ovarian cancers.
    Int J Cancer, 119(6): 1338-44. [Abstract] [Full-text]
21. Dietary fiber intake and subsequent risk of colorectal cancer: the Japan Public Health Center-based prospective study.
    Int J Cancer, 119(6): 1475-80. [Abstract] [Full-text]
22. Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression.
    Int J Cancer, 119(6): 1285-90. [Abstract] [Full-text]
23. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence.
    Int J Cancer, 119(6): 1440-6. [Abstract] [Full-text]
24. Red palm oil suppresses the formation of azoxymethane (AOM) induced aberrant crypt foci (ACF) in Fisher 344 male rats.
    Food Chem Toxicol, 44(10): 1667-73. [Abstract] [Full-text]
25. Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps.
    Biochem Pharmacol, 72(6): 729-38. [Abstract] [Full-text]
26. Colorectal cancer: screening double-contrast barium enema examination in average-risk adults older than 50 years.
    Radiology, 240(3): 725-35. [Abstract] [Full-text]
27. Contrast-enhanced CT for differentiation of ovarian metastasis from gastrointestinal tract cancer: stomach cancer versus colon cancer.
    AJR Am J Roentgenol, 187(3): 741-5. [Abstract] [Full-text]
28. MRI of rectal disorders.
    AJR Am J Roentgenol, 187(3): W275-84. [Abstract] [Full-text]
29. Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo.
    Oncogene, 25(37): 5145-54. [Abstract] [Full-text]
30. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act".
    Am J Clin Pathol, 126(4): 564-71. [Abstract] [Full-text]
31. Promoting culturally appropriate colorectal cancer screening through a health educator: a randomized controlled trial.
    Cancer, 107(5): 959-66. [Abstract] [Full-text]
32. Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001.
    Cancer, 107(5): 1153-61. [Abstract] [Full-text]
33. Geographic variation in the incidence of colorectal cancer in the United States, 1998-2001.
    Cancer, 107(5): 1172-80. [Abstract] [Full-text]
34. Demographics and tumor characteristics of colorectal cancers in the United States, 1998-2001.
    Cancer, 107(5): 1112-20. [Abstract] [Full-text]
35. Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975-2001.
    Cancer, 107(5): 1162-71. [Abstract] [Full-text]
36. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001.
    Cancer, 107(5): 1142-52. [Abstract] [Full-text]
37. Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1988-2000.
    Cancer, 107(5): 1189-95. [Abstract] [Full-text]
38. Decreased levels of mucosal detoxification enzymes in the pouch of patients with familial adenomatous polyposis.
    Br J Surg, 93(9): 1108-14. [Abstract] [Full-text]
39. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population.
    Br J Surg, 93(9): 1115-22. [Abstract] [Full-text]
40. CDC-funded intervention research aimed at promoting colorectal cancer screening in communities.
    Cancer, 107(5): 1196-204. [Abstract] [Full-text]
41. A population-based study of colorectal cancer histology in the United States, 1998-2001.
    Cancer, 107(5): 1128-41. [Abstract] [Full-text]
42. Associations of subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis with county-level poverty, by race and sex.
    Cancer, 107(5): 1121-7. [Abstract] [Full-text]
43. Rural/nonrural differences in colorectal cancer incidence in the United States, 1998-2001.
    Cancer, 107(5): 1181-8. [Abstract] [Full-text]
44. Social deprivation and outcomes in colorectal cancer.
    Br J Surg, 93(9): 1123-31. [Abstract] [Full-text]
45. Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III.
    Int J Cancer, 119(8): 1829-36. [Abstract] [Full-text]
46. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer.
    Int J Cancer, 119(8): 1863-8. [Abstract] [Full-text]
47. Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines.
    Int J Cancer, 119(8): 1837-42. [Abstract] [Full-text]
48. Celecoxib for the prevention of colorectal adenomatous polyps.
    N Engl J Med, 355(9): 885-95. [Abstract] [Full-text]
49. Celecoxib for the prevention of sporadic colorectal adenomas.
    N Engl J Med, 355(9): 873-84. [Abstract] [Full-text]
50. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.
    J Clin Oncol, 24(25): 4085-91. [Abstract] [Full-text]
51. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone.
    J Clin Oncol, 24(25): 4078-84. [Abstract] [Full-text]
52. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.
    J Clin Oncol, 24(25): 4069-77. [Abstract] [Full-text]
53. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    J Clin Oncol, 24(25): 4062-8. [Abstract] [Full-text]

© 2004-2010 Colorectal Cancer Research Today. All Rights Reserved.